XML 39 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Repurchase Program
12 Months Ended
Aug. 27, 2022
Equity  
Stock Repurchase Program

Note K – Stock Repurchase Program

During 1998, the Company announced a program permitting the Company to repurchase a portion of its outstanding shares not to exceed a dollar maximum established by the Company’s Board of Directors. On March 23, 2021, the Board voted to increase the repurchase authorizartion from $24.7 to $26.2 billion. The Board voted to increase the repurchase authorization by $1.5 billion on October 5, 2021, $1.5 billion on December 15, 2021 and $2.0 billion on March 22, 2022, bringing the total authorization to $31.2 billion. The Company has $1.1 billion remaining under the Board’s authorization to repurchase its common stock.

The Company’s share repurchase activity consisted of the following:

​

​

​

​

​

​

​

​

​

​

​

​

Year Ended

​

    

August 27,

    

August 28,

    

August 29,

(in thousands)

​

2022

​

2021

​

2020

​

​

​

​

​

​

​

​

​

​

Amount

​

$

4,359,991

​

$

3,378,321

​

$

930,903

Shares

​

 

2,220

​

 

2,592

​

 

826

​

During fiscal year 2022, the Company retired 2.5 million shares of treasury stock which had previously been repurchased under the Company’s share repurchase program. The retirement increased Retained deficit by $3.3 billion and decreased Additional paid-in capital by $293.0 million. During the comparable prior year period, the Company retired 1.0 million shares of treasury stock, which increased Retained deficit by $1.1 billion and decreased Additional paid-in capital by $60.0 million.

On October 4, 2022, the Board voted to authorize the repurchase of an additional $2.5 billion of the Company’s common stock in connection with the Company’s ongoing share repurchase program. Since the inception of the repurchase program in 1998, the Board has authorized $33.7 billion in share repurchases. Subsequent to August 27, 2022 and through October 17, 2022, the Company has repurchased 203,856 shares of common stock at an aggregate cost of $442.6 million. Considering the cumulative repurchases and the increase in authorization subsequent to August 27, 2022 and through October 17, 2022, the Company has $3.1 billion remaining under the Board’s authorization to repurchase its common stock.